Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-031267
Filing Date
2011-05-26
Accepted
2011-05-26 16:35:04
Documents
1
Period of Report
2011-05-24

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c17942_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c17942_4x0.xml 4 3914
  Complete submission text file 0001209191-11-031267.txt   5398
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
HENNEY CHRISTOPHER S (Reporting) CIK: 0001242880 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 11874494